Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Dietary Fiber, Glycemic Load, and Risk of Non—insulin-dependent Diabetes Mellitus in Women
1997 Standout
Pathogenesis of type 2 diabetes mellitus
2004
Thiazolidinediones
2004 Standout
Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.
1992
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Impaired Glucose Tolerance as a Disorder of Insulin Action
1988
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo
2011
C-Reactive protein is inversely related to physical fitness in middle-aged subjects
2004
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Cost-Effective Whole-Cell Assay for Laboratory Evolution of Hydroxylases in Escherichia coli
2001 StandoutNobel
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
2008
Gestational diabetes mellitus
2005 Standout
Relationship Between Tumor Cell Load and Sensitivity to the Cytostatic Effect of Two Novel Platinum-bile Acid Complexes, Bamet-D3 and Bamet-UD2
2002
Exercise Standards for Testing and Training
2013 Standout
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women
2001 Standout
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
1997
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
2004 Standout
The Continuing Epidemics of Obesity and Diabetes in the United States
2001 Standout
Exercise in a behavioural weight control programme for obese patients with Type 2 (non-insulin-dependent) diabetes
1988
Cellular mechanisms of insulin resistance
2000 Standout
Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter1
1997
Evidence for prescribing exercise as therapy in chronic disease
2006
The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*
1991
Central nervous system control of food intake
2000 StandoutNature
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Type 2 diabetes
2017 Standout
Diabetes and Atherosclerosis
2002 Standout
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes
1990
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Physical Activity and Reduced Occurrence of Non-Insulin-Dependent Diabetes Mellitus
1991
Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm� feasibility study
1991
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
2001 Standout
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
2006
Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
1988
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
1987
Prediabetes: a high-risk state for diabetes development
2012 Standout
Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity and Type 2 Diabetes Mellitus in Women
2003 Standout
Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase
2002 StandoutNobel
Obesity and insulin resistance
2000 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Influence of body fat distribution on free fatty acid metabolism in obesity.
1989
Engineered Alkane‐Hydroxylating Cytochrome P450BM3 Exhibiting Nativelike Catalytic Properties
2007 StandoutNobel
Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus
1988
The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and Type 2 (non-insulin-dependent) diabetes mellitus
1985
Strength Training Increases Insulin-Mediated Glucose Uptake, GLUT4 Content, and Insulin Signaling in Skeletal Muscle in Patients With Type 2 Diabetes
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Metabolic effects of a low-glycemic-index diet
1987
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes
1989 StandoutNobel
Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3
2006 StandoutNobel
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Exercise and Type 2 Diabetes
2000
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Alpha 1-adrenergic receptor activation mobilizes cellular Ca2+ in a muscle cell line.
1984
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
2001
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
1989
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Control of lipolysis and its relevance to development of obesity in man
1988
Preparation of individual human diploid fibroblasts and study of ion transport
1985
Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients
2006
PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity
2010
Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes
1991
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
1998
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Gout
2021 Standout
Westernisation, insulin resistance and diabetes in Australian Aborigines
1991
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic Control
1993
Role of Insulin Resistance in Human Disease
1988 Standout
Accelerated gastric emptying in hypertensive subjects.
1997
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity
1992
Variations in Insulin-Stimulated Glucose Uptake in Healthy Individuals with Normal Glucose Tolerance*
1987
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Primary Prevention of Diabetes Mellitus
1988
A Controlled Randomized Study on the Effect of Long‐term Physical Exercise on the Metabolic Control in Type 2 Diabetic Patients
1986
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
2008
Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.
1986
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Barbara Vasquez being referenced
Hyperinsulinemia in obesity: Lack of relation to gastric emptying of glucose solution or to plasma somatostatin levels
1983
Elevated In Vivo Insulin Clearance in Pima Indians with Non-insulin-dependent Diabetes Mellitus
1985
Improvement of Insulin Secretion but Not Insulin Resistance after Short Term Control of Plasma Glucose in Obese Type II Diabetics*
1982
NADP-specific isocitrate dehydrogenase of Escherichia coli
1979
Very-Low-Density Lipoprotein Triglyceride Metabolism in Non-insulin-dependent Diabetes Mellitus: Relationship to Plasma Insulin and Free Fatty Acids
1983
Measurement of intracellular volume in monolayers of cultured cells
1982
Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal
1984
Improvement of Glucose Homeostasis After Exercise Training in Non-insulin-dependent Diabetes
1984
Biphasic Patterns of Peripheral Insulin and Glucose Levels After Lunch in Normal Subjects
1987
The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*
1984